蛋白质氨酸甲基转移酶2控制了急性髓性白血病的炎症信号
Camille Sauter1, Thomas Morin2, Fabien Guidez2
1Inserm UMR 1231, Epi2THM team, LabEx LipSTIC Team, UFR des Sciences de Santé, Université de Bourgogne, Dijon, France. camille.sauter@u-bourgogne.fr.
Communications biology
|June 20, 2024
概括
蛋白质氨酸甲基转移酶2 (PRMT2) 调节急性髓性白血病 (AML) 的炎症. 低PRMT2表达与AML患者的炎症特征和较差的存活率相关,突出其关键作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 氨酸甲基化,由蛋白氨酸甲基转移酶 (PRMTs) 催化,影响细胞过程,包括癌症.
- 在各种癌症中,PRMT2表达升高,但其在急性髓性白血病 (AML) 中的功能尚不清楚.
研究的目的:
- 研究PRMT2在急性髓性白血病 (AML) 中的作用.
- 探索PRMT2表达,炎症和AML患者存活率之间的关系.
主要方法:
- 在AML患者队列中分析PRMT2表达.
- 使用PRMT2淘汰 (KO) AML细胞系和Prmt2 KO小鼠模型.
- 研究炎症信号通路,包括NF-κB和STAT3.3.
主要成果:
- 在AML患者中,低PRMT2表达体显示出炎症特征 (例如NF-κB通路) 的丰富和较低的生存率.
- 在LPS治疗后,Prmt2 KO小鼠巨体表现出增加的促炎性细胞因子信号传递.
- 在AML细胞中PRMT2的枯竭导致IL6的过度产生,NF-κB的放松调节,以及STAT3的过度激活.
结论:
- 在急性髓性白血病中,PRMT2作为炎症的关键调节剂.
- 由PRMT2失调驱动的异常炎症信号,有助于AML的发病.
- PRMT2状态可以作为AML的预后指标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K


